FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children
Summary by NE Iowa Publishing
7 Articles
7 Articles
All
Left
Center
4
Right

+4 Reposted by 4 other sources
FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children
WEDNESDAY, March 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has expanded its indication of Odactra, a house dust mite allergen tablet, for the treatment of house dust mite-induced allergic rhinitis, with or without conjunctivitis, to include…
Coverage Details
Total News Sources7
Leaning Left0Leaning Right0Center4Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage